The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of BRAF mutation and effectiveness of BRAF inhibitor on the brain metastases in patients with metastatic melanoma.
Tulasi Gummadi
No relevant relationships to disclose
Roxana Stefania Dronca
No relevant relationships to disclose
Chul Kim
No relevant relationships to disclose
Lisa A. Kottschade
No relevant relationships to disclose
Rajendar K Mittapalli
No relevant relationships to disclose
William F. Elmquist
No relevant relationships to disclose
Arkadiusz Dudek
No relevant relationships to disclose